BIOSK — Unibios Holdings SA Income Statement
0.000.00%
Last trade - 00:00
- €22.00m
- €29.22m
- €11.24m
- 14
- 41
- 77
- 37
R2018 December 31st | 2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8.03 | 8.34 | 7.3 | 8.48 | 11.2 |
Cost of Revenue | |||||
Gross Profit | 3.05 | 3.44 | 2.7 | 3.12 | 4.19 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7.8 | 7.58 | 6.87 | 7.56 | 9.86 |
Operating Profit | 0.229 | 0.758 | 0.43 | 0.921 | 1.39 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.27 | 0.305 | 0.042 | 0.552 | 0.998 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.393 | 0.1 | -0.091 | 0.334 | 0.651 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.397 | 0.1 | -0.091 | 0.334 | 0.651 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.397 | 0.1 | -0.091 | 0.334 | 0.651 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.108 | 0.006 | -0.005 | 0.021 | 0.042 |
Dividends per Share | |||||
Special Dividends per Share |